STAAR Surgical Company (STAA) Stock Analysis & Investment Frameworks
STAAR Surgical Company (STAA) stock analysis on Invetso. Review STAAR Surgical Company’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
STAAR Surgical Company Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Medical - Instruments & Supplies
- Country: US
STAAR Surgical Company Key Financial Metrics
- Market Cap: $1.13B
- Revenue: $239.44M
- ROE: 1.08%
- ROIC: 1.90%
- Dividend Yield: N/A
About STAAR Surgical Company
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
STAAR Surgical Company Investment Frameworks
Invetso analyzes STAAR Surgical Company (STAA) across the following frameworks:
- STAAR Surgical Company 10Y Growth Potential
- STAAR Surgical Company Scenario Analysis
- STAAR Surgical Company Risks & Opportunities
- STAAR Surgical Company Economic Moat
- STAAR Surgical Company Business Model
- STAAR Surgical Company Management
- STAAR Surgical Company SWOT Analysis
- STAAR Surgical Company Porter's 5 Forces
- STAAR Surgical Company PESTLE Analysis
- STAAR Surgical Company ESG Analysis

